Cryopreservation Bags and Freezing Bags Market

Cryopreservation Bags and Freezing Bags Market: Distribution by Type of Analyte Stored and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    35

  • Pages
    267

  • View Count
    11810

Cryopreservation bags and Freezing Bags Market Overview

The global market for cryopreservation bags and freezing bags is expected to grow up to US$ 316 million in 2035 growing at compounded annual growth rate (CAGR) of 8% during the forecast period. Cryopreservation is a technique that aids in maintaining biological materials at cryogenic temperatures for an extended period of time, while preserving the original cell structures. Owing to its ability to store a wide variety of elements, including cells, tissues, blood and DNA, cryopreservation has emerged as a key focus area for stakeholders in the biopharmaceutical industry. It is worth highlighting that, since 1980s, there have been significant advancements made in the cryopreservation methods used for storing stem cells, particularly hematopoietic stem cells and embryonic stem cells, which are essential in various medical applications, including regenerative medicines and biobanking.

Driven by the rising demand for promising storage containers that safeguard the quality, viability, stability, and integrity of the preserved samples, cryopreservation bags, also known as cryobags, have emerged as the most reliable and safest choice for storage. These cryopreservation bags and freezing bags provide researchers and drug developers with rapid access to vital components used across research focused on cellular and genetic therapies, diagnosis and drug development. Hence, with the advancement of technologies, a surge in morbidity across the globe and growing demand for advanced therapeutic medicinal products (ATMPs), the cryopreservation bags market and freezing bags market is anticipated to witness substantial growth during the forecast period.

The image provides a list of freezing bags companies. At present, more than 30 players are engaged in the manufacturing of over 70 cryopreservation bags by integrating a wide spectrum of polymer compositions; majority of these players are headquartered in Europe The image looks at the distribution of companies offering cryopreservation bags and freezing bags. Several players across the globe are offering cryo bags to facilitate long-term preservation of a wide variety of samples, including ATMPs and cord blood stem cells In pursuit of gaining a competitive edge, the cryopreservation bags and freezing bags providers are focused on upgrading their existing capabilities and enhancing their cryogenic focused product portfolios

Key Market Insights

The Cryopreservation Bags and Freezing Bags Market: Distribution by Type of Analyte Stored (Blood, Biologics and Tissues) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the cryopreservation bags and freezing bags market, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the cryobags market are briefly discussed below. 

Rising Interest in ATMPs and Biobanking to Drive Cryopreservation Bags and Freezing Bags Market

ATMPs are revolutionary therapies for human use that are based on genes, tissues or cells and present novel therapeutic prospects for treating a wide range of disorders. Cryopreservation plays a crucial role in the ATMP production process as it extends the shelf life of raw materials and final products.  Furthermore, cryopreservation facilitates extensive testing of the raw materials before they undergo manufacturing, thereby enhancing patient safety. Despite the expensive and limited storage strategies, the cryopreservation bags market (blood, biologics and tissues) is expected to experience accelerated market growth due to the growing need for biobanking and the increase in popularity of cell therapies and gene therapies.

Market Landscape: Companies Integrate EVA based Polymer Compositions to Manufacture Cryogenic EVA Bags 

The cryopreservation bags and freezing bags providers landscape features a mix of large, mid-sized and small companies that offer various cryobags. Presently, more than 70 cryogenic storage bags for biologic products have been / are being developed by over 30 industry stakeholders to enable long-term preservation of various materials. Further, cryobags can be used to store a wide spectrum of analytes; of these, 50% are capable of storing blood, followed by those storing cell cultures (44%), biologics (21%) and tissues (21%). It is worth highlighting that Miltenyi Biotec’s CryoMACS freezing bags can store blood and cell cultures and have obtained ISO 13845 certification. The company received CE marking for marketing across EU in 2009 and FDA 510(k) clearance in 2010 for marketing in the US.

Another factor that influences the manufacturing of cryopreservation bags in pursuit of sustaining biological materials in cold chains is choosing the ideal form of packaging material. It is important to highlight that a significant portion of commercially available cell freezing bags are primarily made of ethylene vinyl acetate (EVA) and polyvinyl chloride (PVC) polymer compositions. In this context, it is worth highlighting that in February 2022, OriGen Biomedical launched its cryopreservation product, CryoStore FLEX freezing bag. This EVA bag is intended for the storage of blood components and has received CE mark clearance that confirms its compliance with specific requirements of the European medical device directives. 

Cryopreservation Bags and Freezing Bags Market Size: Blood Market Segment Holds the Largest Market Share

Driven by advancements in biomedical research, the growing prevalence of blood disorders and transfusion rates, and rising demand for ATMPs, cord blood stem cells and biobanking applications, lucrative opportunities are expected to emerge for companies offering cryogenic storage products. The cryopreservation bags and freezing bags market is anticipated to grow at a CAGR of 8% during the forecast period 2023-2035. 

In terms of type of analyte stored, blood bags capture 55% share of the cryopreservation bags and freezing bags market. However, in terms of market growth, the tissue freezing bags market size is expected to grow at a relatively high CAGR of 11% during the forecast period. Further, amongst the key geographical regions, Asia-Pacific is anticipated to capture the highest blood bags market share in 2035, with India and China being the major contributors to this industry. For instance, an India based company, CellBios, provides CellStor Freezing EVA bags for the cryopreservation of blood and blood components, tissues, organs, biologic therapies, ATMPs, and cells, including stem cell cryopreservation. 

Being a relatively concentrated market, cyropreservation bags and freezing bags companies are focused on developing unique selling propositions for their products and becoming strategic partners for therapy developers The image looks at the demand of freezing bags. In 2035, blood bags are likely to account for 55% of the total demand for cryopreservation bags and freezing bags; this can be attributed to the growing prevalence of blood disorders and transfusion rates The snapshot provides a view on cyropreservation bags and freezing bags demand in million units. The demand for cryopreservation bags and freezing bags for storing biologics is rising significantly, owing to the surge in the popularity of cell and gene therapies; by 2035, it is anticipated to reach over 2.5 million units

Key Trends: A Number of Cryobags are Intended for Shipping as well as Storage Purposes

Many stakeholders are undertaking initiatives to achieve greater durability in cryopreservation bags. Cryopreservation bags are specially designed containers used to store biological samples at ultra-low temperatures or in liquid nitrogen, typically below -150 degrees Celsius (-238 degrees Fahrenheit). Undoubtedly, cryobags are effective in preserving biological materials, however, they still possess limitations in terms of long-term durability and robustness. 

Further, EVA (ethylene-vinyl acetate) is believed to undergo glass transition at temperatures lower than -15 degrees Celsius, which makes it fragile and susceptible to breakage, leaving EVA bags vulnerable to contaminations. This has prompted stakeholders to shift from conventional packaging materials to unparalleled packaging materials, such as polytetrafluoroethylene (PTFE) and fluorinated ethylene propylene (FEP). It is worth highlighting that these materials are likely to be more widely recognized for exhibiting greater resilience for long-term applications. ,   Given the inclination of stakeholders towards exploring novel innovative approaches that boost durability, we believe that the cryopreservation bags and freezing bags market size is likely to evolve at a rapid pace over the forecast period.

Key Cryopreservation Bags and Freezing Bags Producing Companies

Examples of companies engaged in this industry include (which have also been captured in this report) American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical and Sartorius. This market report includes an easily searchable excel database of all the companies providing cryopreservation and freezing bags for biologics, blood, cell cultures and tissues.

Recent Developments in Cryopreservation Bags and Freezing Bags Market

Several recent developments have taken place in the field of cryopreservation bags and freezing bags. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In February 2022, OriGen received CE mark approval for the CryoStore™ FLEX Freezing Bag product line. Additionally, the company announced the global launch of CryoStore™ FLEX freezing bag. 
  • In June 2023, SCTbio collaborated with Cyto-carein in order to improve the quality of cryopreservation for cell therapy development in Europe.
The image provides cyropreservation bags and freezing bags market forecast. The projected future opportunity for cryopreservation bags and freezing bags for biologics storage is expected to be well distributed across different types of biologics and key geographical regions Cryopreservation bags and freezing bags for tissue storage hold a prominent share of the current demand and is spread across various geographies; US, China and India account for more than 60% of the total demand
The image looks at the freezing bags market segmentation. The cryopreservation bags and freezing bags market for tissue storage is likely to grow at a steady pace till 2035; the projected future opportunity is expected to be well distributed across key geographical regions

Scope of the Report

The market report presents an in-depth analysis of the various firms / organizations that are engaged in this market, across different segments, as defined in the below table: 

Key Report Attributes Details

Historical Trend

2018 – 2022

Base Year

2022

Forecast Period

2023 – 2035

Market Size 2023

$ 215 million

CAGR

~8%

Type of Analyte Stored

Blood

Biologics

Tissues

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and North Africa, and Rest of the World

Key Companies Profiled

  • American Durafilm
  • Biomed Device
  • CellBios
  • Charter Medical
  • Instant Systems
  • Macopharma
  • OriGen Biomedical
  • Sartorius
  • (Full list of more than 30 cryopreservation bags and freezing bags providers captured in the developer landscape analysis of the report)

Customization Scope

  • 15% Free Customization Option

PowerPoint Presentation (Complimentary)

  • Available

Excel Data Packs (Complimentary)

  • Market Landscape and Developer Landscape Analysis
  • Product Competitiveness Analysis
  • Market Concentration Analysis
  • Market Assessment and Opportunity Analysis: Blood
  • Market Assessment and Opportunity Analysis: Biologics
  • Market Assessment and Opportunity Analysis: Tissues

The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the research report includes:

  • A preface providing introduction to the full report, Cryopreservation Bags and Freezing Bags Market, 2023-2035.
  • An executive summary of the insights captured during our research, offering a high-level view on the current state of the cryopreservation bags and freezing bags market and its likely evolution in the given forecast period.
  • A general overview of the role of cryopreservation / freezing bags in the healthcare industry, along with details on the different types of analytes stored in them. It also highlights the advantages and limitations of cryopreservation bags. Further, the chapter concludes with a discussion on future perspectives in this domain. 
  • A detailed assessment of the overall market landscape of cryopreservation bags and freezing bags, based on several relevant parameters, such as type of analyte stored (biologics, blood, cell cultures and tissues), storage temperature (cryogenic (<-65°C), frozen (-65°C to -10°C) and ambient (>-10°C)), application area (storage and shipping), and type of packaging layer (single packaging and double packaging). 
  • An in-depth analysis of the current companies providing cryopreservation bags and freezing bags, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of analyte stored and number of products offered. 
  • An insightful competitiveness analysis of cryopreservation bags and freezing bags offered by players across various regions (North America, Europe, and Asia-Pacific and Rest of the World), based on supplier strength (in terms of years of experience and company size), product competitiveness (type of analyte stored, application area and nominal volume range) and number of product variables. 
  • Elaborate profiles of key manufacturers (shortlisting criteria includes companies providing more than two products and established before 2011) that offer cryopreserving bags and freezing bags for storing various types of analytes, including biologics, blood, cell cultures and tissues. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook. In addition, it also includes short profiles for nine cryopreservation bag and freezing bag providers.
  • A detailed analysis, highlighting the market concentration of industry stakeholders across various regions, based on several relevant parameters, such as industry experience, company size, number of products offered and type of analyte stored. 
  • An informed estimate of the annual demand for cryopreservation bags and freezing bags (in terms of units of bags required for storing blood, biologics and tissues), across various geographical regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World).

One of the key objectives of the market report was to estimate the current market size, opportunity and the future growth potential of the cryopreservation bags and freezing bags market. We have provided an informed estimate on the likely evolution of the market for the forecast period, 2023-2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on several relevant parameters, such as type of analyte stored (biologics, blood, tissues), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios, representing different tracks of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this industry. The report features detailed transcripts of interviews held with the following individuals:

  • Director, Product Management, Mid-sized Company, USA
  • Product Specialist, Very Large Company, USA
  • Business Manager, Mid-sized Company, Austria

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What is cryopreservation in biology?

Answer: Cryopreservation is the use of very low temperatures to preserve structurally intact living cells and tissues for a long period of time.

Question 2: What are the steps in cryopreservation of biologic products?

Answer: The major steps in cryopreservation are: (1) mixing of cryoprotective agents (CPA) with cells or tissues before cooling; (2) cooling of the cells or tissues at low temperatures at which the metabolic processes of the cells stop; (3) thawing of the cells or tissues; and (4) removal of CPAs from the cells or tissues after thawing. The appropriate use of CPAs is, therefore, important to improve the viability of the sample to be cryopreserved.

Question 3: What are the different methods of cryopreservation?

Answer: Generally, there are two basic methods of cryopreservation, the conventional slow freezing (SF) and the rapid freezing method, also known as vitrification (Vit). These protocols require different concentrations of CPAs and appropriate cooling rates.

Question 4: What is a cryobag?

Answer: A cryobag is a bag designed for the cryopreservation of cellular products in a closed-bag system at ultra-low or cryogenic temperatures.

Question 5: How many storage bags have been developed for the purpose of cryopreservation?

Answer: More than 70 bags are currently available, across the globe for the storage and preservation of different biological samples.

Question 6: Who are the leading manufacturers providing cryopreservation bags and freezing bags?

Answer: At present, more than 30 companies are engaged in providing cryopreservation and freezing bags. Examples of leading companies engaged in this market (which have also been captured in this report) include American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical and Sartorius.

Question 7: Which region captures the largest share in the cryopreservation bags and freezing bags market?

Answer: Presently, the cryopreservation bags and freezing bags market is dominated by North America, followed by Asia-Pacific.

Question 8: What is the likely market growth rate (CAGR) for cryopreservation bags and freezing bags market?

Answer: The cryopreservation bags and freezing bags market is projected to grow at an annualized rate (CAGR) of ~8%, during the forecast period 2023-2035.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com